Evidence map›Paper›PMID 27956702›Full record

ArticleMolecular and cellular biology2017

Snail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks Tumorigenesis.

Arathy S Kumar, Sankar Jagadeeshan, Ravi Shankar Pitani, Vijayalakshmi Ramshankar, Kesavan Venkitasamy, Ganesh Venkatraman, Suresh K Rayala

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Downregulation of NOncotarget · 2018
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Arathy S KumarDepartment of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, India.
Sankar JagadeeshanDepartment of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, India.
Ravi Shankar PitaniDepartment of Community Medicine, Sri Ramachandra University, Chennai, India.
Vijayalakshmi RamshankarDepartment of Preventive Oncology, Cancer Institute (WIA), Chennai, India.
Kesavan VenkitasamyDepartment of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, India.
Ganesh VenkatramanDepartment of Human Genetics, Sri Ramachandra University, Chennai, India ganeshv@sriramachandra.edu.in rayala@iitm.ac.in.
Suresh K RayalaDepartment of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, India ganeshv@sriramachandra.edu.in rayala@iitm.ac.in.
Indian Institute of Technology Madras · INSri Ramachandra Institute of Higher Education and Research · INCancer Institute (WIA) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we have identified one microRNA, microRNA 493 (miR-493), which could simultaneously and directly regulate multiple genes downstream of the insulin-like growth factor 1 receptor (IGF1R) pathway, including IGF1R, by binding with complementary sequences in the 3' untranslated region (UTR) of mRNAs of IGF1R, insulin receptor substrate 1 (IRS1), and mitogen-activated protein kinase 1 (MAPK1), thereby potentiating their inhibitory function at multiple levels in development and progression of cancers. This binding was further confirmed by pulldown of miR with AGO-2 antibody. Further, results from head and neck samples showed that miR-493 levels were significantly downregulated in tumors, with a concomitant increase in the expression of IGF1R and key downstream effectors. Functional studies from miR-493 overexpression cells and nude-mouse models revealed the tumor suppressor functions of miR-493. Regulation studies revealed that Snail binds to the miR-493 promoter and represses it. We found the existence of a dynamic negative feedback loop in the regulation of IGF1R and miR-493 mediated via Snail. Our study showed that nicotine treatment significantly decreases the levels of miR-493-with a concomitant increase in the levels of Snail-an indication of progression of cells toward tumorigenesis, reestablishing the role of tobacco as a major risk factor for head and neck cancers and elucidating the mechanism behind nicotine-mediated tumorigenesis.

Indexed as

Feedback, PhysiologicalSignal TransductionAnimalsBinding SitesCarcinogenesisCell Line, TumorCell ProliferationDown-RegulationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHead and Neck NeoplasmsHumansKineticsMice, NudeMicroRNAsMicroRNAsMIRN493 microRNA, humanNicotineReceptor, IGF Type 1Snail Family Transcription Factorsfeedback loopIGF1RmiR-493nicotineSnail

Identifiers

PMID27956702
PMCPMC5335515
OpenAlexW2563540786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.